SCHEMBL22668462

SCHEMBL22668462

O=C(Nc1nnc(-c2ccc(F)cc2)o1)N1CCC(N2CCCCC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADCY1 Q08828 8/20 0.52
▸ KDM4E B2RXH2 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ LMNA P02545 2/20 0.47
▸ HTT P42858 2/20 0.47
▸ ADCY8 P40145 1/20 0.47
▸ CHRNA7 P36544 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22668781 0.89 ADCY1 (0.60) ADCY1KDM4EKMT2ALMNAHTT
SCHEMBL22668461 0.89 ADCY1 (0.60) ADCY1KDM4EKMT2ALMNAHTT
SCHEMBL22668490 0.88 ADCY1 (0.61) ADCY1KDM4EKMT2ALMNAHTT
SCHEMBL22668487 0.87 ADCY1 (0.48) ADCY1ADCY8POLB
SCHEMBL22668902 0.86 ADCY1 (0.54) ADCY1KDM4ELMNAHTTADCY8
SCHEMBL22668590 0.85 ADCY1 (0.56) ADCY1KDM4ELMNAHTTADCY8
SCHEMBL22668563 0.84 ADCY1 (0.55) ADCY1KDM4EMEN1KMT2ALMNA
SCHEMBL22668516 0.83 ADCY1 (0.53) ADCY1KDM4ELMNAHTTADCY8
SCHEMBL22668585 0.83 ADCY1 (0.53) ADCY1KDM4ELMNAHTTADCY8
SCHEMBL22668588 0.82 ADCY1 (0.53) ADCY1KDM4ELMNAHTTADCY8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200361882-A1 METABOLICALLY STABLE N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS MICROBIOTIX, INC. (US) 2020-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361882-A1 METABOLICALLY STABLE N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS RIOX2, MRPS35, AADAC ADCY1 3421/4885KDM4E 3350/4885MEN1 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback